2027 Medicare Final Rules: Significant Changes Ahead for Remote Patient Monitoring Companies

The CY 2027 Medicare final rules change who may furnish RPM and RTM services, add an initiating-visit requirement, and reset the payment math. What monitoring companies should do now.

11/12/20262 min read

The CY 2027 Medicare Physician Fee Schedule (PFS) final rule includes several changes that remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) companies need to understand. While some changes take effect January 1, 2027, one of the most consequential provisions won't become effective until 2029.

For companies providing outsourced monitoring services, the implications could be substantial.

1. CMS Restricts Outsourced Clinical Monitoring Beginning in 2029

Perhaps the most significant change is CMS's decision to require clinical personnel performing RPM and RTM services to be direct employees of the billing practitioner or practice.

CMS provided a two-year transition period, making the requirement effective January 1, 2029.

This creates a significant challenge for RPM companies that provide turnkey monitoring services, including contracted nurses and other clinical personnel.

Importantly, the restriction does not necessarily prevent companies from supplying devices, software platforms, or other technology services. However, companies whose business models depend on outsourced clinical monitoring will need to evaluate their staffing arrangements and contractual relationships.

2. Initiating Visit Requirements Change in 2027

Beginning January 1, 2027, CMS will require a separately reportable initiating visit before RPM or RTM billing begins.

The visit may be conducted in person or through eligible telehealth services. RPM or RTM must be discussed during the encounter, although it does not need to be the primary purpose of the visit.

For RPM providers, this means patient enrollment and billing workflows may need to be modified to ensure compliance.

3. CMS Does Not Finalize Proposed Bundled RPM/RTM Codes

CMS considered replacing portions of the existing RPM and RTM payment structure with four bundled HCPCS G-codes.

Ultimately, CMS declined to finalize the proposal.

This is particularly important for companies relying on separate reimbursement for device supply and treatment management services.

The existing CPT coding framework remains in place, although CMS finalized changes to code valuation that could affect reimbursement in 2027.

4. Physician Payment Changes Will Affect RPM Economics

The 2027 PFS final rule includes reductions to the Medicare conversion factors, including a 2.31% decrease for practitioners who do not qualify for the Advanced Alternative Payment Model conversion factor.

However, individual RPM and RTM code payments may change by different amounts depending on their finalized relative value units.

Companies should evaluate reimbursement at the CPT code level rather than assume a uniform percentage reduction.

5. The Hospital Outpatient Final Rule Is Not an Across-the-Board RPM Payment Increase

Although CMS finalized a 2.3% net increase in hospital outpatient payment rates for 2027, that increase should not be interpreted as a corresponding increase in RPM reimbursement.

The distinction between physician professional billing and hospital outpatient facility reimbursement remains important.

What Should RPM Companies Be Doing Now?

For companies operating in the RPM and RTM markets, I would prioritize three activities:

  • Evaluate existing clinical staffing and outsourced monitoring arrangements.

  • Update patient enrollment, initiating-visit documentation, and billing workflows for 2027.

  • Model the financial and operational impact of the finalized payment changes and the 2029 staffing restriction.

The 2029 implementation date may seem distant, but companies that rely heavily on outsourced clinical monitoring should begin evaluating alternative business models now.

The larger issue isn't simply what Medicare will pay for RPM in 2027. It's who will be permitted to furnish the services that support that reimbursement.

That distinction could fundamentally change how some RPM companies operate.

Unlock Market Access Success
Expertise in MedTech Solutions